Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02270814
Title Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
Acronym CACTUX
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
University of Mississippi Medical Center Jackson Mississippi 39216 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Sanford Roger Maris Cancer Center Fargo North Dakota 58122 United States Details
Sanford Cancer Center Oncology Clinic and Pharmacy Sioux Falls South Dakota 57104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field